ENDOCARDITIS CAUSED BY HACEK GROUP MICROORGANISMS
https://doi.org/10.17802/2306-1278-2025-14-6-249-258
Abstract
Highlights
A systematic review of modern scientific data on the etiology, epidemiology, pathogenesis, features of laboratory diagnostics and etiotropic treatment of endocarditis by HACEK was conducted. To analyze the research, we used information platforms and scholarly search services such as PubMed, Web of Science, Google Scholar, eLIBRARY.RU, and CyberLeninka. The search was carried out by keywords; after the initial analysis, 45 articles were selected. Further study of the epidemiological, clinical, immunopathological and microbiological aspects of Infective endocarditis by HACEK is necessary.
Abstract
Infective endocarditis caused by HACEK group microorganisms (Haemophilus spp., Aggregatibacter spp., Cardiobacterium spp., Eikenella corrodens, and Kingella spp.) is a rare but potentially life-threatening condition that requires timely diagnosis and adequate treatment. This review analyzes current data on the epidemiology, microbiological features, diagnosis, treatment, and prognosis of HACEK endocarditis. Regional differences in the prevalence of the disease, risk factors, and predictors of its development in various patient categories are highlighted. The clinical manifestations of HACEK endocarditis are characterized in detail. The possibilities of laboratory diagnosis of HACEK endocarditis with an emphasis on culture and molecular genetic methods are considered. Modern approaches to antibacterial therapy and surgical treatment of the disease, taking into account the increasing antibiotic resistance of pathogens, are analyzed. Data on hospital mortality of patients with HACEK endocarditis are presented. Unresolved problems and promising directions for further research of this pathology are identified.
About the Authors
Maria V. SvishchevaRussian Federation
PhD, Associate Professor, Moscow University for Industry and Finance “Synergy”, Moscow, Russian Federation
Vitaly A. Sidnyaev
Russian Federation
Clinical Psychologist, Medical Student, Moscow University for Industry and Finance “Synergy”, Moscow, Russian Federation
Maria A. Kuznetsova
Russian Federation
PhD, Associate Professor, Moscow University for Industry and Finance “Synergy”, Moscow, Russian Federation
Mikhail M. Pechatkin
Russian Federation
Medical Student, Moscow University for Industry and Finance “Synergy”, Moscow, Russian Federation
Konstantin V. Vardov
Russian Federation
Medical Student, Moscow University for Industry and Finance “Synergy”, Moscow, Russian Federation
References
1. Demin A.A., Kobalava J.D., Skopin I.I., Tyurin V.P., Boytsov S.A., Go - lukhova E.Z., Gordeev M.L., Gudymovich V.D., Demchenko E.A., Drobysheva V.P., Domonova E.A., Drapkina O.M., Zagorodnikova K.A., Irtyuga O.B., Kakhktsyan P.S., Kozlov R.S., Kotova E.O., Medvedev A.P., Muratov R.M., Nikolaevsky E.N., Pisaryuk A.S., Ponomareva E.Yu., Popov D.A., Rakhina S.A., Revishvili A.G., Reznik I.I., Ryzhkova D.S., Safarova A.F., Tazina S.Ya., Chipigina N.S., Shipulina O.Yu., Shlyakhto E.S., SchneiderYu.A., Shostak N.A. Infectious endocarditis and infection of intracardiac devices in adults. Clinical guidelines 2021. Russian Journal of Cardiology. 2022;27(10):5233. (In Russ.) doi:10.15829/1560-4071-2022-5233.
2. Kotova E., Domonova E.A., Kobalava Z.D., Moiseeva A.Y. Clinical and diagnostic value of including PCR blood test in the traditional algorithm for identifying causative agents of infective endocarditis: a cohort study of 124 patients. Terapevticheskii arkhiv. 2023;95(1):23-31. https://doi.org/10.26442/00403660.2023.01.202042.
3. Bush L.M. Infections Caused by HACEK Bacteria / L.M. Bush, M.T. Vazquez-Pertejo. MSD Manual. Professional Version. 2022. Режим доступа: https://www.msdmanuals.com/professional/infectious-diseases/gram-negative-bacilli/infections-caused-by-hacek-bacteria.
4. Sharara S. L., Tayyar R., Kanafani Z. A., Kanj S.S. HACEK endocarditis: a review. Expert Review of Anti-Infective Therapy.2016;14(6):539–545. https://doi.org/10.1080/14787210.2016.1184085/
5. Karunakaran R., Marret M.J., Hassan H., Puthucheary S.D.. Eikenella corrodens from a brain abscess. Malays J Pathol. 2004;26(1):49-52. PMID: 16190107.
6. Danilov A.I., Krechikova O.I. Aggregatibacter actinomycetemcomitans: clinical significance, diagnosis, antimicrobial therapy. Clinical microbiology and antimicrobial chemotherapy. 2012;14(4):276–279. (In Russ.). https://elibrary.ru/item.asp?id=18271397
7. Kosikowska U., Biernasiuk A., Rybojad P. Haemophilus parainfluenzae as a marker of the upper respiratory tract microbiota changes under the influence of preoperative prophylaxis with or without postoperative treatment in patients with lung cancer. BMC Microbiol. 2016;16:62. https://doi.org/10.1186/s12866-016-0679-6
8. Holden R., Lewkenbandara R., Pasztor M., Okonkwo E.K. Cardiobacterium hominis endocarditis complicated by aortic root abscess: a case report. Access Microbiol. 2019;1(10). https://doi.org/10.1099/acmi.0.000051.
9. Berge A., Morenius C., Petropoulos A. Epidemiology, bacteriology, and clinical characteristics of HACEK bacteremia and endocarditis: a population-based retrospective study. Eur J Clin Microbiol Infect Dis. 2021; 40:525–534. https://doi.org/10.1007/s10096-020-04035-y.
10. Lutzen L., Olesen B., Voldstedlund M., Christensen J.J., Moser C., Knudsen J.D., Fuursted K., Hartmeyer G.N., Chen M., Sondergaard T.S., Rosenvinge F.S., Dzajic E., Schonheyder H.C., Norskov-Lauritsen N. Incidence of HACEK bacteraemia in Denmark: a 6-year population-based study. Int J Infect Dis. 2028; 68:83–87. https://doi.org/10.1016/j.ijid.2018.01.025
11. Ambrosioni J., Martinez-Garcia C., Llopis J., Garcia-de-la-Maria C., Hernández-Meneses M., Tellez A., Falces C., Almela M., Vidal B., Sandoval E., Fuster D., Quintana E., Tolosana J.M., Marco F., Moreno A., Miró J.M. The Hospital Clinic Infective Endocarditis Investigators. HACEK infective endocarditis: Epidemiology, clinical features, and outcome: A case-control study. Int J Infect Dis. 2018;76:120-125. https://doi.org/10.1016/j.ijid.2018.08.013.
12. Bläckberg A., Morenius C., Olaison L., Berge A., Rasmussen M. Infective endocarditis caused by HACEK group bacteria-a registry-based comparative study. Eur J Clin Microbiol Infect Dis. 2021;40(9):1919-1924. https://doi.org/10.1007/s10096-021-04240-3
13. Chambers S.T., Murdoch D., Morris A. HACEK infective endo-carditis: characteristics and outcomes from a large, multi-national cohort. PLoS ONE. [Internet]. 2013;8(5):e63181. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC365688
14. Brouqui P., Raoult D. Endocarditis due to rare and fastidious bacteria. Clinical microbiology reviews. 2001;14(1):177-207. https://doi.org/10.1128/cmr.14.1.177-207.2001
15. Dale S., Tayyem Z., Maceyko S. Endocarditis: A Review of Recent Literature. Curr Emerg Hosp Med Rep. 2024;12:67–73. https://doi.org/10.1007/s40138-024-00292-9
16. Khaledi M., Sameni F., Afkhami H., Hemmati J., Asareh Zadegan Dezfuli A., Sanae M.J., Validi M. (2022). Infective endocarditis by HACEK: a review. J Cardiothor Surg. 2022;17(1), 185. 5 https://doi.org/10.1186/s13019-022-01932-5
17. Wilson W., Taubert K.A., Gewitz M., Lockhart P.B., Baddour L.M., Levison M. Prevention of infective endocarditis: guidelines from the American heart association: a guideline from the American heart association rheumatic fever, endocarditis, and Kawasaki disease committee, council on cardiovascular disease in the young, and the council on clinical cardiology, council on cardiovascular surgery and anesthesia, and the quality of care and outcomes research interdisciplinary working group. Circulation. 2007;116(15):1736–54. https://doi.org/10.1161/CIRCULATIONAHA.106.183095
18. Habib G., Lancellotti P., Antunes M.J., Bongiorni M.G., Casalta J P., Del Zotti F. ESC guidelines for the management of infective endocarditis: the task force for the management of infective endocarditis of the European society of cardiology (ESC) endorsed by: European association for cardio thoracic surgery (EACTS), the European association of nuclear medicine (EANM). Eur Heart J. 2015;36(44):3075–128. https://doi.org/10.1093/eurheartj/ehv319
19. Del Giudice C, Vaia E, Liccardo D, Marzano F, Valletta A, Spagnuolo G, Ferrara N, Rengo C, Cannavo A, Rengo G. Infective Endocarditis: A Focus on Oral Microbiota. Microorganisms. 2021; 9(6):1218. https://doi.org/10.3390/microorganisms9061218
20. Das M., Badley A.D., Cockerill F.R., Steckelberg J.M., Wilson W.R. Infective endocarditis caused by HACEK microorganisms. Annu Rev Med. 1997;48:25-33. https://doi.org/10.1146/annurev.med.48.1.25.
21. Sima L. Sharara, Ralph Tayyar, Zeina A. Kanafani & Souha S. Kanj HACEK endocarditis: a review, Expert Review of Anti-infective Therapy. 2016;14:6:539-545, https://doi.org/10.1080/14787210.2016.1184085
22. Paturel L., Casalta J.P., Habib G., Nezri M., Raoult D. Actinobacillus actinomycetemcomitans endocarditis. Clin Microbiol Infect. 2004;10(2):98–118. https://doi.org/10.1111/j.1469-0691.2004.00794.x
23. Baddour L.M., Wilson W.R., Bayer A.S., Fowler Jr.V.G., Tleyjeh I.M., Rybak M. J. American Heart Association Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young, Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and Stroke Council. Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American Heart Association. Circulation. 2015;132(15):1435-1486. https://doi.org/10.1161/CIR.0000000000000296
24. Dhapa N., Rodriguez H., Lingam D. Uncommon presentation of Haemophilus parainfluenzae bacteremia: A case study on aortic valve endocarditis // SAGE Open Medical Case Reports. 2024; 12. https://doi.org/10.1177/2050313X241306239
25. Darras-Joly C., Lortholary O., Mainardi J-L., Etienne, J., Guillevin, L., Acar, J. Haemophilus endocarditis: report of 42 cases in adults and review. Haemophilus Endocarditis Study Group. Clin Infect Dis Off Publ Infect Dis Soc Am. 1997;24(6):1087–1094. https://doi.org/10.1086/513624
26. Lutokhina Yu. A., Andrushchishina T.B., Erdniev T.N., Mekhtieva G.A., Petushkov I.L., Yasneva A.S., Blagova O.V. Hema-tologic mask of infective endocarditis as a cause of fever of unknown origin: a case report. Cardiovascular Therapy and Prevention. 2024; 23(8):4070. https://doi.org10.15829/1728-8800-2024-4070
27. Li M., Kim J.B., Sastry B.K.S., Chen M. Infective endocarditis. Lancet. 2024; 27 (10450):P. 377-392. https://doi.org/10.1016/S0140-6736(24)01098-5.
28. Ishikawa T., Shimoyama Y., Kodama Y., Tajika S., Kimura S. Sasaki M. Identification of HACEK Group Bacteria from Blood Samples of Patients with Infective Endocarditis by PCR-RFLP of the 16s rRNA Gene. Research Journal of Microbiology. 2018; 13. 93-99. 10.3923/jm.2018.93.99.
29. Sasaki M., Tajika, S., Kodama Y., Shimoyama Y., Kimura S. Rapid identification of HACEK group bacteria using 16S rRNA gene PCR-RFLP. Interface Oral Health Science 2009:262-264. https://doi.org/10.1007/978-4-431-99644-6_71
30. Couturier M.R., Mehinovic E., Croft A.C., Fisher, M.A. Identification of HACEK clinical isolates by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol. 2011;49(3):1104–1106. https://doi.org/10.1128/jcm.01777-10
31. Ahn Y., Joo L., Suh C.H., Kim S., Shim W.H., Kim S.J., Lee S.A. Impact of brain MRI on the diagnosis of infective endocarditis and treatment decisions: systematic review and meta-analysis. Am J Roentgen. 2022;218(6):958-968. https://doi.org/10.2214/AJR.21.26896
32. Rajani R, Klein JL. Infective endocarditis: A contemporary update. Clin Med (Lond). 2020;20(1):31-35. doi: 10.7861/clinmed.cme.20.1.1
33. Nappi F. Native Infective Endocarditis: A State-of-the-Art-Review. Microorganisms. 2024;12(7):1481. doi: 10.3390/microorganisms12071481
34. Petkovic A., Menkovic N., Petrovic O., Bilbija I., Nisevic M., Radovanovic N. N., Ivanovic B. Imaging in Infective Endocarditis—Current Opinions and Trends in Cardiac Computed Tomography. Diagnostics. 2024;14(13), 1355. https://doi.org/10.3390/diagnostics14131355
35. Revest M., Egmann G., Cattoir V., Tattevin P.. HACEK endocarditis: state-of-the-art. Expert Rev Anti Infect Ther. 2016;14(5):523-30. https://doi.org 10.1586/14787210.2016.1164032.
36. Baddour L.M., Wilson W.R., Bayer A.S., Fowler Jr.V.G., Bolger A.F., Levison M.E., Taubert K.A. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation. 2005;111(23): e394-e434. https://doi.org/10.1161/CIRCULATIONAHA.105.165564
37. Wassef N., Rizkalla E., Shaukat N., Sluka M. HACEK-induced endocarditis. Case Reports. 2013; bcr2012007359. https://doi.org/10.1136/bcr-2012-007359
38. Coburn B., Toye B., Rawte P., Jamieson F.B., Farrell D.J. Patel, S.N. Antimicrobial susceptibilities of clinical isolates of HACEK organisms. Antimicrobial agents and chemotherapy 2013;57(4):1989-91 https://doi.org/10.1128/aac.00111-13
39. Tristram S.G., Pitout M.J., Forward K., Campbell S., Nichols S., Davidson R.J. Characterization of extended-spectrum beta-lactamase-producing isolates of Haemophilus parainfluenzae. J Antimicrob Chemother. 2008;61:509–14. https://doi.org/10.1093/jac/dkm523
40. Takahata S., Ida T., Senju N., Sanbongi Y., Miyata A., Maebashi K., Hoshiko S. Horizontal gene transfer of ftsI, the gene encoding penicillin binding protein 3 in Haemophilus influenzae. Antimicrob Agents Chemother. 2007;51:1589–95. https://doi.org/10.1128/AAC.01545-06
41. Gromkova R.C., Goodgal S. Transformation by plasmid and chromosomal DNAs in Haemophilus parainfluenzae. Biochem Biophys Res Commun. 1979;88:1428–34. https://doi.org/10.1016/0006-291X(79)91139-2
42. Gromkova R.C., Mottalini T.C., Dove M.G. Genetic transformation in Haemophilus parainfluenzae clinical isolates. Curr Microbiol. 1998;37:123–6. https://doi.org/10.1007/s002849900349
43. Le Quellec A., Bessis D., Perez C., Ciurana, A.J. Endocarditis due to beta-lactamase-producing Cardiobacterium hominis. Clin Infect Dis. 1994;19(5):994-5. https://doi.org/10.1093/clinids/19.5.994
44. Lu P.L., Hsueh P.R., Hung C.C., Teng L.J., Jang T.N., Luh K. T. Infective endocarditis complicated with progressive heart failure due to beta-lactamase-producing Cardiobacterium hominis. J Clin Microbiol 2000;38(5):2015-7. https://doi.org/10.1128/jcm.38.5.2015-2017.2000
45. Banerjee A., Kaplan, J.B., Soherwardy A., Nudell Y., Mackenzie, G.A., Johnson S., Balashova, N.V. Characterization of TEM-1 β-Lactamase-Producing Kingella kingae Clinical Isolates. Antimicrob Agents Chemother. 2013;57(9):4300-4306. https://doi.org/10.1128/AAC.00318-13
46. Bidet P., Basmaci R., Guglielmini J., Doit C., Jost C., Birgy A, Bonacorsi S. Genome Analysis of Kingella kingae Strain KWG1 Reveals How a β-Lactamase Gene Inserted in the Chromosome of This Species. Antimicrob Agents Chemother. 2015 Nov 16;60(1):703-8. https://doi.org/10.1128/AAC.02192-15
47. Limonta S., Cambau E., Erpelding M.L., Piau-Couapel C., Goehringer F., Plésiat P., Revest M., Vernet-Garnier V., Le Moing V., Hoen B. Infective Endocarditis Related to Unusual Microorganisms: A Prospective Population-Based Study. Open Forum Infect Dis. 2020;7(5):ofaa127. https://doi.org/10.1093/ofid/ofaa127
Review
For citations:
Svishcheva M.V., Sidnyaev V.A., Kuznetsova M.A., Pechatkin M.M., Vardov K.V. ENDOCARDITIS CAUSED BY HACEK GROUP MICROORGANISMS. Complex Issues of Cardiovascular Diseases. 2025;14(6):249-258. (In Russ.) https://doi.org/10.17802/2306-1278-2025-14-6-249-258

































